Table 2. Summary of the studies on thyroid FNA in Myanmar.
| Author | Year | Hospital | Patients | Distribution by the Bethesda categories (%) | Sensitivity, % | Specificity, % | Accuracy, % | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | V | VI | |||||||
| PM Swe (19) | 1991–1992 | YGH, NYGH | 25 | 1 (4%) | 20 (80%) | – | – | 4 (16%) | – | 100 | 100 | 100 |
| H Oo (20) | 1993–1994 | MGH | 36 | 3 (8.33%) | 27 (75%) | – | – | 2 (5.5%) | 4 (11.1%) | 80 | 100 | 97.5 |
| M Maw (21) | 1996–1997 | YGH, NYGH | 39 | 6 (15.4%) | 17 (43.5%) | – | 14 (35.9%) | 1 (2.6%) | 1 (2.6%) | 100 | 100 | 100 |
| T Oo (22) | 1997–1998 | NOGH, DSGH | 32 | 3 (9.3%) | 25 (78.1%) | – | – | 2 (6.3%) | 2 (6.3%) | 75 | 100 | 96 |
| KK Tun (23) | 2003–2004 | EENT-Mdy, MGH | 50 | 4 (8%) | 33 (66%) | – | 4 (8%) | 4 (8%) | 5 (10%) | 83.3 | 100 | 98 |
| T Soe (24) | 2005–2006 | ORL-HNS | 50 | 0 | 35 (70%) | – | – | 4 (8%) | 11 (22%) | 93 | 94.4 | 94 |
| A Myat (25) | 2006–2007 | YGH, NYGH | 34 | 1 (2.9%) | 29 (85.3%) | – | – | 3 (8.9%) | 1 (2.9%) | 100 | 100 | 100 |
| KS Tun (26) | 2009–2010 | EENT-Mdy | 22 | – | 13 (59.1%) | – | 2 (9.1%) | – | 7 (31.8%) | 100 | 93 | 95 |
| HL Aung (27) | 2015–2017 | ORL-HNS | 170 | 2 (1.2%) | 137(80.6%) | 5 (2.9%) | 8 (4.7%) | 9 (5.3%) | 9 (5.3%) | 64.3 | 100 | 94.1 |
| CNW Lwin (28) | 2017–2018 | MTH, MRH | 82 | 20 (24.3%) | 56 (68.3%) | – | – | 3 (3.7%) | 3 (3.7%) | 100 | 100 | 100 |
FNA, fine-needle aspiration; YGH, Yangon General Hospital; NYGH, New Yangon General Hospital; MGH, Mandalay General Hospital; NOGH, North Okkalapa General Hospital; DSGH, Defence Services General Hospital; EENT-Mdy, Eye, Ear, Nose and Throat Hospital, Mandalay; ORL-HNS, Otorhinolaryngology Head & Neck Surgery Specialist Hospital; MTH, Magway Teaching Hospital; MRH, Magway Regional Hospital.